Patent directory · USPTO A61K / A61P
Patents matching “modified”
433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10064889
Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
granted -
US 10046036
Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria
granted -
US 10039827
Reoviruses having modified sequences
granted -
US 10023581
Modified cytotoxins and their therapeutic use
granted -
US 10016498
D-amino acid derivative-modified peptidoglycan and methods of use thereof
granted -
US 10005811
β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10000523
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 9994527
Modified amino acids
granted -
US 9993502
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9993501
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9986724
Genetically modified non-human animals and methods of use thereof
granted -
US 9969975
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9950010
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9950011
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9937157
Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
granted -
US 9913461
Genetically modified mouse whose genome comprises a humanized CD274 gene
granted -
US 9901082
Genetically modified non-human animals and methods of use thereof
granted -
US 9899614
Phosphorescent tetradentate metal complexes having modified emission spectra
granted -
US 9896481
Modified mini-hepcidin peptides and methods of using thereof
granted -
US 9889160
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9889161
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9888673
Genetically modified cells, tissues, and organs for treating disease
granted -
US 9885026
Modified cascade ribonucleoproteins and uses thereof
granted -
US 9879231
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
granted